Experimental studies are thus critical for assessing the direction and causal relationship between eCB levels and PTSD symptoms, and the use of AEA and 2-AG levels as biomarkers of in vivo FAAH and MAGL inhibitor activity, respectively, may be a key asset for clinical development efforts. Here, FAAH is linked to post-traumatic stress disorder.